// Post a message

Replying to:

A phase Ib/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3

Marc-Eric Halatsch, Richard Kast, Georg Karpel-Massler, Benjamin Mayer, Oliver Zolk, Bernd Schmitz, Angelika Scheuerle, Ludwig Maier, Lars Bullinger, Regine Mayer-Steinacker, Carl Schmidt, Katharina Zeiler, Ziad Elshaer, Patricia Panther, Birgit Schmelzle, Anke Hallmen, Annika Dwucet, Markus D Siegelin, Mike-Andrew Westhoff, Kristine Beckers, Gauthier Bouche, Tim Heiland from the Ulm University Hospital, Ulm, Germany; the Department of Neurosurgery, Cantonal Hospital of Winterthur, CH-8401 (…)

pre-moderation

This forum is pre-moderated: your contribution will only appear after being validated by an admin.

Who are you?
Your post

To create paragraphs, just leave blank lines.